Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01694030
Other study ID # University of Southampton: LO6
Secondary ID
Status Not yet recruiting
Phase Phase 1
First received September 17, 2012
Last updated September 24, 2012
Start date November 2012
Est. completion date December 2014

Study information

Verified date September 2012
Source University of Southampton
Contact Lorna Otway
Phone 447764985326
Email Lorna.Otway@soton.ac.uk
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Interventional

Clinical Trial Summary

The purpose of this study is to explore whether asking participants to visualise a secure attachment figure or a neutral event leads to differences in self-reported felt security or depressed mood. Furthermore, the investigators aim to explore whether it is possible to keep a secure prime activated over 3 days via text message visualisation tasks.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

-Anxiety and depressive symptoms

Exclusion Criteria:

-Bipolar disorder

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Attachment security priming


Locations

Country Name City State
United Kingdom College Keep Southampton Hants

Sponsors (1)

Lead Sponsor Collaborator
University of Southampton

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Depressed Mood 1 Depressed mood will be measured using the depression and anxiety items from the Profile of Mood States (POMS: McNair, Lorr, & Droppleman, 1992), which equates to 24 items out of the original 65 on the POMS. Respondents use a 5-point Likert-type scale (0=Not at all, 4=Extremely) to rate the extent to which they have experienced various mood states over the past week. This questionnaire takes 5 minutes to complete. Depressed mood will be measured on day 7 of the study (immediately after lab primes) No
Secondary Felt Security 1 To find out whether the experimental manipulation was successful, participants will complete a 16-item measure of Felt Security (Luke, Carnelley, & Sedikides, 2012). This scale consists of ten words relating to feelings of security, comfort and safety (e.g., loved, protected). Participants rate the extent to which the person or scenario in the visualisation task made them feel secure, by rating each item using a 6-point Likert-type scale (1=not at all, 6=very much). This measure takes 3 minutes to complete. Felt security will be measured on day 7 of the study (after initial lab primes) No
Secondary Depressed Mood 2 Depressed mood will be measured using the depression and anxiety items from the Profile of Mood States (POMS: McNair, Lorr, & Droppleman, 1992), which equates to 24 items out of the original 65 on the POMS. Respondents use a 5-point Likert-type scale (0=Not at all, 4=Extremely) to rate the extent to which they have experienced various mood states over the past week. This questionnaire takes 5 minutes to complete. Depressed mood will be measured on day 7 of the study (after 3 days of text primes) No
Secondary Depressed Mood 3 Depressed mood will be measured using the depression and anxiety items from the Profile of Mood States (POMS: McNair, Lorr, & Droppleman, 1992), which equates to 24 items out of the original 65 on the POMS. Respondents use a 5-point Likert-type scale (0=Not at all, 4=Extremely) to rate the extent to which they have experienced various mood states over the past week. This questionnaire takes 5 minutes to complete. Depressed mood will be measured on day 11 of the study (24 hours after the last text prime). No
Secondary Felt Security 2 Participants will complete a 16-item measure of Felt Security (Luke, Carnelley, & Sedikides, 2012). This scale consists of ten words relating to feelings of security, comfort and safety (e.g., loved, protected). Participants rate the extent to which the person or scenario in the visualisation task made them feel secure, by rating each item using a 6-point Likert-type scale (1=not at all, 6=very much). This measure takes 3 minutes to complete. Felt security will be measured on day 10 of the study (after 3 days of text primes) No
Secondary Felt Security 3 To find out whether the experimental manipulation was successful, participants will complete a 16-item measure of Felt Security (Luke, Carnelley, & Sedikides, 2012). This scale consists of ten words relating to feelings of security, comfort and safety (e.g., loved, protected). Participants rate the extent to which the person or scenario in the visualisation task made them feel secure, by rating each item using a 6-point Likert-type scale (1=not at all, 6=very much). This measure takes 3 minutes to complete. Felt security will be measured on day 11 of the study (24 hours after last text prime) No
See also
  Status Clinical Trial Phase
Completed NCT03256162 - Ketamine as an Adjunctive Therapy for Major Depression Phase 1
Recruiting NCT05570110 - Enoxolone in Major Depression - Biomarker-outcome Relationship Phase 1/Phase 2
Completed NCT02530164 - Transcranial Direct Current Stimulation (tDCS) As Treatment for Major Depression N/A
Completed NCT00964054 - Depression Outcomes Study of Exercise Phase 1
Completed NCT01447602 - A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior Phase 3
Completed NCT00517387 - The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression Phase 3
Recruiting NCT04939649 - Ketamine as an Adjunctive Therapy for Major Depression (2) Phase 3
Recruiting NCT05894980 - How to Reduce Suicidal Thoughts and Impulsivity in Depression N/A
Terminated NCT04712968 - Efficacy of Daylight as Adjunctive Treatment in Patients With Depression N/A
Enrolling by invitation NCT04717921 - Assesment of Retinal Nerve Fiber Layer in First Episode Depressive Patients Using Selective Serotonin Reuptake Inhibitor
Recruiting NCT03358056 - Effects of Mindfulness Based Cognitive Therapy on Emotional Processing N/A
Recruiting NCT03711019 - Efficacy of Convulsive Therapies During Continuation N/A
Completed NCT02104232 - Thinking Healthy Program - Peer Delivered, India (THPP-I) N/A
Completed NCT02111915 - Thinking Healthy Program - Peer Delivered (Pakistan) N/A
Terminated NCT01219686 - EScitalopram PIndolol ONset of Action Phase 2/Phase 3
Completed NCT00158990 - Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression. Phase 3
Completed NCT01049347 - Amitriptyline and Paroxetine Treatment of Major Depression Phase 3
Completed NCT03268434 - Evaluation of Metacognitive Training for Depression (D-MCT) in Outpatient Care N/A
Completed NCT01880957 - PET and MRI Brain Imaging of Bipolar Disorder N/A
Completed NCT04420793 - Voice Changes During ECT